Pneumopathy Osteoplastic

Osteoplastic pneumopathy (pneumoostopathy) is a rare disease characterized by a pathological process in which the lung parenchyma is replaced by connective tissue, followed by the formation of bone tissue.

The etiology and pathogenesis of the disease are unknown. Pneumoostopathy is associated with a hereditary predisposition, as well as with exposure to various external factors, such as smoking, inhalation of toxic substances, exposure to radiation, etc.

Clinical manifestations of pneumostopopathy can be different and depend on the stage of development of the disease. At the initial stage of osteoplastic pneumopathy, periodic chest pain, cough, shortness of breath, and increased body temperature may be observed. In the future, chronic pneumonia, emphysema, and pleurisy may develop.

Diagnosis of osteoplastic pneumopathy is based on data from lung radiography, computed tomography, and magnetic resonance imaging.

Treatment of osteoplastic pneumopathy can be conservative or surgical. Conservative treatment includes taking anti-inflammatory drugs, antibiotics, and bronchodilators to improve respiratory function. Surgical treatment may include resection of the affected area of ​​the lungs, removal of cysts, etc. The prognosis for osteoplastic pneumopathy depends on the stage of the disease and the severity of its course.

Osteoplastic pneumopathy is a serious disease that requires timely diagnosis and treatment.

Osteoplastic pneumopathy is a rather rare disease and therefore it is difficult to find an exact definition of this term. But essentially it is pneumonia, complicated by the formation of bone tissue in the lungs, which occurs due to the fact that the pneumoplastic patient is a heavy smoker, abuses alcohol, or has a metabolic disorder. Pnev